Using AI at AstraZeneca: from clinical trial design to regulatory

Watch on-demand

Webinar

Using AI at AstraZeneca: from clinical trial design to regulatory

In the fast-paced environment of drug development, pharmaceutical companies need to mine internal and external information quickly and accurately. Many organizations are looking for innovations with NLP (Natural Language Processing), such as large language models, to accelerate drug development. In this webinar, we will discuss how AI (Artificial Intelligence) and NLP are being used at AstraZeneca to facilitate clinical trial design, diversity plans, and health authority advice within regulatory affairs.

Register now to learn about:

What is NLP
NLP for efficacy endpoints and clinical trial design
NLP to accelerate diversity plans preparation
NLP implementation into digital platform to mine health authority advice

Meet the Speakers

Emilie Louvet

Director Regulatory Data Products at AstraZeneca

Constantinos Katevatis

Associate Director, R&D NLP at IQVIA

To watch on-demand, simply complete the form.

Work Email Address*

Ask a question early

Our presenter will carry out a live Q&A, if you have any questions please let us know.

Yes, I would like to hear more from an IQVIA expert

I have read and agree to the below privacy policies*

Lead Source - PI Partner

Primary Product Interest

You agree Citeline and IQVIA may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and IQVIA.